Transdermal Patch Industry Research Report 2024
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
According to APO Research, the global Transdermal Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The report will help the Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Transdermal Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The report will help the Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Teva Pharmaceutical
- Nitto Denko
- Grьnenthal
- IBSA Group
- GSK
- Luye Pharma Group
- Pfizer
- Chattem
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Endo International
- Beijing Tide Pharmaceutical
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
- Rx Channel
- OTC Channel
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Transdermal Patch Market Size (2019-2030) & (US$ Million)
2.2.2 Global Transdermal Patch Sales (2019-2030)
2.2.3 Global Transdermal Patch Market Average Price (2019-2030)
2.3 Transdermal Patch by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Methyl Salicylate-based Patch
2.3.3 Rivastigmine Transdermal Patch
2.3.4 Fentanyl Transdermal Patch
2.3.5 Lidocaine Patch
2.3.6 Diclofenac Patch
2.3.7 Nicotine Transdermal Patch
2.3.8 Others
2.4 Transdermal Patch by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Rx Channel
2.4.3 OTC Channel
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Transdermal Patch Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Transdermal Patch Sales (M Pcs) of Manufacturers (2019-2024)
3.3 Global Transdermal Patch Revenue of Manufacturers (2019-2024)
3.4 Global Transdermal Patch Average Price by Manufacturers (2019-2024)
3.5 Global Transdermal Patch Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Transdermal Patch, Product Type & Application
3.8 Global Manufacturers of Transdermal Patch, Date of Enter into This Industry
3.9 Global Transdermal Patch Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Hisamitsu Pharmaceutical
4.1.1 Hisamitsu Pharmaceutical Company Information
4.1.2 Hisamitsu Pharmaceutical Business Overview
4.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
4.1.5 Hisamitsu Pharmaceutical Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Company Information
4.2.2 Johnson & Johnson Business Overview
4.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
4.2.5 Johnson & Johnson Recent Developments
4.3 Novartis
4.3.1 Novartis Company Information
4.3.2 Novartis Business Overview
4.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Novartis Transdermal Patch Product Portfolio
4.3.5 Novartis Recent Developments
4.4 UCB Pharma
4.4.1 UCB Pharma Company Information
4.4.2 UCB Pharma Business Overview
4.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.4.4 UCB Pharma Transdermal Patch Product Portfolio
4.4.5 UCB Pharma Recent Developments
4.5 Mylan
4.5.1 Mylan Company Information
4.5.2 Mylan Business Overview
4.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Mylan Transdermal Patch Product Portfolio
4.5.5 Mylan Recent Developments
4.6 Teva Pharmaceutical
4.6.1 Teva Pharmaceutical Company Information
4.6.2 Teva Pharmaceutical Business Overview
4.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
4.6.5 Teva Pharmaceutical Recent Developments
4.7 Nitto Denko
4.7.1 Nitto Denko Company Information
4.7.2 Nitto Denko Business Overview
4.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Nitto Denko Transdermal Patch Product Portfolio
4.7.5 Nitto Denko Recent Developments
4.8 Grьnenthal
4.8.1 Grьnenthal Company Information
4.8.2 Grьnenthal Business Overview
4.8.3 Grьnenthal Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Grьnenthal Transdermal Patch Product Portfolio
4.8.5 Grьnenthal Recent Developments
4.9 IBSA Group
4.9.1 IBSA Group Company Information
4.9.2 IBSA Group Business Overview
4.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.9.4 IBSA Group Transdermal Patch Product Portfolio
4.9.5 IBSA Group Recent Developments
4.10 GSK
4.10.1 GSK Company Information
4.10.2 GSK Business Overview
4.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.10.4 GSK Transdermal Patch Product Portfolio
4.10.5 GSK Recent Developments
4.11 Luye Pharma Group
4.11.1 Luye Pharma Group Company Information
4.11.2 Luye Pharma Group Business Overview
4.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
4.11.5 Luye Pharma Group Recent Developments
4.12 Pfizer
4.12.1 Pfizer Company Information
4.12.2 Pfizer Business Overview
4.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Pfizer Transdermal Patch Product Portfolio
4.12.5 Pfizer Recent Developments
4.13 Chattem
4.13.1 Chattem Company Information
4.13.2 Chattem Business Overview
4.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Chattem Transdermal Patch Product Portfolio
4.13.5 Chattem Recent Developments
4.14 Dr Reddy’s Laboratories
4.14.1 Dr Reddy’s Laboratories Company Information
4.14.2 Dr Reddy’s Laboratories Business Overview
4.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
4.14.5 Dr Reddy’s Laboratories Recent Developments
4.15 Bayer
4.15.1 Bayer Company Information
4.15.2 Bayer Business Overview
4.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Bayer Transdermal Patch Product Portfolio
4.15.5 Bayer Recent Developments
4.16 Mundipharma
4.16.1 Mundipharma Company Information
4.16.2 Mundipharma Business Overview
4.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Mundipharma Transdermal Patch Product Portfolio
4.16.5 Mundipharma Recent Developments
4.17 Endo International
4.17.1 Endo International Company Information
4.17.2 Endo International Business Overview
4.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Endo International Transdermal Patch Product Portfolio
4.17.5 Endo International Recent Developments
4.18 Beijing Tide Pharmaceutical
4.18.1 Beijing Tide Pharmaceutical Company Information
4.18.2 Beijing Tide Pharmaceutical Business Overview
4.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
4.18.5 Beijing Tide Pharmaceutical Recent Developments
5 GLOBAL TRANSDERMAL PATCH MARKET SCENARIO BY REGION
5.1 Global Transdermal Patch Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Transdermal Patch Sales by Region: 2019-2030
5.2.1 Global Transdermal Patch Sales by Region: 2019-2024
5.2.2 Global Transdermal Patch Sales by Region: 2025-2030
5.3 Global Transdermal Patch Revenue by Region: 2019-2030
5.3.1 Global Transdermal Patch Revenue by Region: 2019-2024
5.3.2 Global Transdermal Patch Revenue by Region: 2025-2030
5.4 North America Transdermal Patch Market Facts & Figures by Country
5.4.1 North America Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Transdermal Patch Sales by Country (2019-2030)
5.4.3 North America Transdermal Patch Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Transdermal Patch Market Facts & Figures by Country
5.5.1 Europe Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Transdermal Patch Sales by Country (2019-2030)
5.5.3 Europe Transdermal Patch Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Transdermal Patch Market Facts & Figures by Country
5.6.1 Asia Pacific Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Transdermal Patch Sales by Country (2019-2030)
5.6.3 Asia Pacific Transdermal Patch Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Transdermal Patch Market Facts & Figures by Country
5.7.1 Latin America Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Transdermal Patch Sales by Country (2019-2030)
5.7.3 Latin America Transdermal Patch Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
5.8.1 Middle East and Africa Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Transdermal Patch Sales by Country (2019-2030)
5.8.3 Middle East and Africa Transdermal Patch Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Transdermal Patch Sales by Type (2019-2030)
6.1.1 Global Transdermal Patch Sales by Type (2019-2030) & (M Pcs)
6.1.2 Global Transdermal Patch Sales Market Share by Type (2019-2030)
6.2 Global Transdermal Patch Revenue by Type (2019-2030)
6.2.1 Global Transdermal Patch Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Transdermal Patch Revenue Market Share by Type (2019-2030)
6.3 Global Transdermal Patch Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Transdermal Patch Sales by Application (2019-2030)
7.1.1 Global Transdermal Patch Sales by Application (2019-2030) & (M Pcs)
7.1.2 Global Transdermal Patch Sales Market Share by Application (2019-2030)
7.2 Global Transdermal Patch Revenue by Application (2019-2030)
7.2.1 Global Transdermal Patch Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Transdermal Patch Revenue Market Share by Application (2019-2030)
7.3 Global Transdermal Patch Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Transdermal Patch Value Chain Analysis
8.1.1 Transdermal Patch Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Transdermal Patch Production Mode & Process
8.2 Transdermal Patch Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Transdermal Patch Distributors
8.2.3 Transdermal Patch Customers
9 GLOBAL TRANSDERMAL PATCH ANALYZING MARKET DYNAMICS
9.1 Transdermal Patch Industry Trends
9.2 Transdermal Patch Industry Drivers
9.3 Transdermal Patch Industry Opportunities and Challenges
9.4 Transdermal Patch Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Transdermal Patch Market Size (2019-2030) & (US$ Million)
2.2.2 Global Transdermal Patch Sales (2019-2030)
2.2.3 Global Transdermal Patch Market Average Price (2019-2030)
2.3 Transdermal Patch by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Methyl Salicylate-based Patch
2.3.3 Rivastigmine Transdermal Patch
2.3.4 Fentanyl Transdermal Patch
2.3.5 Lidocaine Patch
2.3.6 Diclofenac Patch
2.3.7 Nicotine Transdermal Patch
2.3.8 Others
2.4 Transdermal Patch by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Rx Channel
2.4.3 OTC Channel
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Transdermal Patch Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Transdermal Patch Sales (M Pcs) of Manufacturers (2019-2024)
3.3 Global Transdermal Patch Revenue of Manufacturers (2019-2024)
3.4 Global Transdermal Patch Average Price by Manufacturers (2019-2024)
3.5 Global Transdermal Patch Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Transdermal Patch, Product Type & Application
3.8 Global Manufacturers of Transdermal Patch, Date of Enter into This Industry
3.9 Global Transdermal Patch Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Hisamitsu Pharmaceutical
4.1.1 Hisamitsu Pharmaceutical Company Information
4.1.2 Hisamitsu Pharmaceutical Business Overview
4.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
4.1.5 Hisamitsu Pharmaceutical Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Company Information
4.2.2 Johnson & Johnson Business Overview
4.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
4.2.5 Johnson & Johnson Recent Developments
4.3 Novartis
4.3.1 Novartis Company Information
4.3.2 Novartis Business Overview
4.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Novartis Transdermal Patch Product Portfolio
4.3.5 Novartis Recent Developments
4.4 UCB Pharma
4.4.1 UCB Pharma Company Information
4.4.2 UCB Pharma Business Overview
4.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.4.4 UCB Pharma Transdermal Patch Product Portfolio
4.4.5 UCB Pharma Recent Developments
4.5 Mylan
4.5.1 Mylan Company Information
4.5.2 Mylan Business Overview
4.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Mylan Transdermal Patch Product Portfolio
4.5.5 Mylan Recent Developments
4.6 Teva Pharmaceutical
4.6.1 Teva Pharmaceutical Company Information
4.6.2 Teva Pharmaceutical Business Overview
4.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
4.6.5 Teva Pharmaceutical Recent Developments
4.7 Nitto Denko
4.7.1 Nitto Denko Company Information
4.7.2 Nitto Denko Business Overview
4.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Nitto Denko Transdermal Patch Product Portfolio
4.7.5 Nitto Denko Recent Developments
4.8 Grьnenthal
4.8.1 Grьnenthal Company Information
4.8.2 Grьnenthal Business Overview
4.8.3 Grьnenthal Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Grьnenthal Transdermal Patch Product Portfolio
4.8.5 Grьnenthal Recent Developments
4.9 IBSA Group
4.9.1 IBSA Group Company Information
4.9.2 IBSA Group Business Overview
4.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.9.4 IBSA Group Transdermal Patch Product Portfolio
4.9.5 IBSA Group Recent Developments
4.10 GSK
4.10.1 GSK Company Information
4.10.2 GSK Business Overview
4.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.10.4 GSK Transdermal Patch Product Portfolio
4.10.5 GSK Recent Developments
4.11 Luye Pharma Group
4.11.1 Luye Pharma Group Company Information
4.11.2 Luye Pharma Group Business Overview
4.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
4.11.5 Luye Pharma Group Recent Developments
4.12 Pfizer
4.12.1 Pfizer Company Information
4.12.2 Pfizer Business Overview
4.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Pfizer Transdermal Patch Product Portfolio
4.12.5 Pfizer Recent Developments
4.13 Chattem
4.13.1 Chattem Company Information
4.13.2 Chattem Business Overview
4.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Chattem Transdermal Patch Product Portfolio
4.13.5 Chattem Recent Developments
4.14 Dr Reddy’s Laboratories
4.14.1 Dr Reddy’s Laboratories Company Information
4.14.2 Dr Reddy’s Laboratories Business Overview
4.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
4.14.5 Dr Reddy’s Laboratories Recent Developments
4.15 Bayer
4.15.1 Bayer Company Information
4.15.2 Bayer Business Overview
4.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Bayer Transdermal Patch Product Portfolio
4.15.5 Bayer Recent Developments
4.16 Mundipharma
4.16.1 Mundipharma Company Information
4.16.2 Mundipharma Business Overview
4.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Mundipharma Transdermal Patch Product Portfolio
4.16.5 Mundipharma Recent Developments
4.17 Endo International
4.17.1 Endo International Company Information
4.17.2 Endo International Business Overview
4.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Endo International Transdermal Patch Product Portfolio
4.17.5 Endo International Recent Developments
4.18 Beijing Tide Pharmaceutical
4.18.1 Beijing Tide Pharmaceutical Company Information
4.18.2 Beijing Tide Pharmaceutical Business Overview
4.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
4.18.5 Beijing Tide Pharmaceutical Recent Developments
5 GLOBAL TRANSDERMAL PATCH MARKET SCENARIO BY REGION
5.1 Global Transdermal Patch Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Transdermal Patch Sales by Region: 2019-2030
5.2.1 Global Transdermal Patch Sales by Region: 2019-2024
5.2.2 Global Transdermal Patch Sales by Region: 2025-2030
5.3 Global Transdermal Patch Revenue by Region: 2019-2030
5.3.1 Global Transdermal Patch Revenue by Region: 2019-2024
5.3.2 Global Transdermal Patch Revenue by Region: 2025-2030
5.4 North America Transdermal Patch Market Facts & Figures by Country
5.4.1 North America Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Transdermal Patch Sales by Country (2019-2030)
5.4.3 North America Transdermal Patch Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Transdermal Patch Market Facts & Figures by Country
5.5.1 Europe Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Transdermal Patch Sales by Country (2019-2030)
5.5.3 Europe Transdermal Patch Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Transdermal Patch Market Facts & Figures by Country
5.6.1 Asia Pacific Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Transdermal Patch Sales by Country (2019-2030)
5.6.3 Asia Pacific Transdermal Patch Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Transdermal Patch Market Facts & Figures by Country
5.7.1 Latin America Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Transdermal Patch Sales by Country (2019-2030)
5.7.3 Latin America Transdermal Patch Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
5.8.1 Middle East and Africa Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Transdermal Patch Sales by Country (2019-2030)
5.8.3 Middle East and Africa Transdermal Patch Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Transdermal Patch Sales by Type (2019-2030)
6.1.1 Global Transdermal Patch Sales by Type (2019-2030) & (M Pcs)
6.1.2 Global Transdermal Patch Sales Market Share by Type (2019-2030)
6.2 Global Transdermal Patch Revenue by Type (2019-2030)
6.2.1 Global Transdermal Patch Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Transdermal Patch Revenue Market Share by Type (2019-2030)
6.3 Global Transdermal Patch Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Transdermal Patch Sales by Application (2019-2030)
7.1.1 Global Transdermal Patch Sales by Application (2019-2030) & (M Pcs)
7.1.2 Global Transdermal Patch Sales Market Share by Application (2019-2030)
7.2 Global Transdermal Patch Revenue by Application (2019-2030)
7.2.1 Global Transdermal Patch Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Transdermal Patch Revenue Market Share by Application (2019-2030)
7.3 Global Transdermal Patch Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Transdermal Patch Value Chain Analysis
8.1.1 Transdermal Patch Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Transdermal Patch Production Mode & Process
8.2 Transdermal Patch Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Transdermal Patch Distributors
8.2.3 Transdermal Patch Customers
9 GLOBAL TRANSDERMAL PATCH ANALYZING MARKET DYNAMICS
9.1 Transdermal Patch Industry Trends
9.2 Transdermal Patch Industry Drivers
9.3 Transdermal Patch Industry Opportunities and Challenges
9.4 Transdermal Patch Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
